Ascelia Pharma AB (publ) (STO:ACE)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.030
+0.105 (3.59%)
Feb 10, 2026, 5:29 PM CET

Ascelia Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
49.8675.2621.86149.56261.6
Cash & Short-Term Investments
49.8675.2621.86149.56261.6
Cash Growth
-33.75%244.34%-85.39%-42.83%41.64%
Other Receivables
2.776.12.995.165.87
Receivables
2.776.12.995.165.87
Prepaid Expenses
1.160.610.660.790.96
Other Current Assets
0.151.753.435.366.18
Total Current Assets
53.9483.7228.94160.87274.61
Property, Plant & Equipment
0.940.121.060.631.82
Other Intangible Assets
57.0757.0857.0757.0757.06
Other Long-Term Assets
-0--00-
Total Assets
111.94140.9287.07218.57333.49
Accounts Payable
2.044.731.5315.886.15
Accrued Expenses
8.4812.738.5219.6616.34
Short-Term Debt
-25.23---
Current Portion of Leases
0.90.170.880.291.1
Current Income Taxes Payable
----0.01
Other Current Liabilities
0.9719.111.641.691.51
Total Current Liabilities
12.461.9812.5737.5225.11
Long-Term Leases
0.07-0.180.190.55
Other Long-Term Liabilities
----0-
Total Liabilities
12.4761.9812.7437.7125.66
Common Stock
127.997.1934.8734.8734.58
Additional Paid-In Capital
771.37721.75678.75678.75678.83
Retained Earnings
-800.9-740.97-639.96-533.73-405.83
Comprehensive Income & Other
1.110.970.670.970.25
Shareholders' Equity
99.4778.9474.33180.86307.83
Total Liabilities & Equity
111.94140.9287.07218.57333.49
Total Debt
0.9725.41.060.481.66
Net Cash (Debt)
48.8949.8620.8149.07259.94
Net Cash Growth
-1.94%139.76%-86.05%-42.65%42.12%
Net Cash Per Share
0.430.920.624.287.89
Filing Date Shares Outstanding
126.8496.1133.7633.6733.67
Total Common Shares Outstanding
126.8496.1133.7633.6733.67
Working Capital
41.5421.7416.37123.35249.51
Book Value Per Share
0.780.822.205.379.14
Tangible Book Value
42.421.8717.25123.79250.77
Tangible Book Value Per Share
0.330.230.513.687.45
Machinery
-0.60.60.60.6
Source: S&P Global Market Intelligence. Standard template. Financial Sources.